Company profile: Pro-Spectus
1.1 - Company Overview
Company description
- Provider of healthcare advisory services specializing in the pharmaceutical, medical device, and diagnostic healthcare industries, offering a Patient Access Program that enables patient and market access to therapies by optimizing the patient access journey.
Products and services
- Healthcare Advisory Services: Delivers sector-specific advisory across pharmaceutical, medical device, and diagnostic healthcare industries, reflecting specialization across these domains
- Patient Access Program: Market access-focused program that enables patient and market access to therapies by optimizing the patient access journey
- Pharmaceutical Advisory Services: Industry-focused advisory for the pharmaceutical industry, leveraging specialization in healthcare to support sector needs within pharmaceutical contexts
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pro-Spectus
Emmes
HQ: United States
Website
- Description: Provider of clinical research services as a contract research organization for public health and biopharmaceutical innovation, collaborating with leading researchers to tackle global public health challenges.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emmes company profile →
DiscoveryBioMed
HQ: United States
Website
- Description: Provider of life sciences and biotechnology focused on integrating human cell physiology with the drug discovery critical path, based in Birmingham, AL.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DiscoveryBioMed company profile →
Genetic
HQ: Italy
Website
- Description: Provider of integrated pharmaceutical research, development, manufacturing and licensing of pharmaceutical specialties and medical devices, focused on respiratory and ophthalmology. Offers proprietary medicines (nebulization and oral liquids, tablets, capsules), ophthalmic and respiratory products (pMDI, nebulizers), preservative-free eye drops and nasal sprays, out-licensing/third-party production, and pharmacovigilance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genetic company profile →
SFL
HQ: Switzerland
Website
- Description: Provider of integrated consultancy solutions to pharma, biotech and medtech companies for global and local activities, with in-house expertise across product life cycle functions including Regulatory Affairs & Regulatory Intelligence, Quality & Supply Chain, and Medical Writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SFL company profile →
Science Group
HQ: United Kingdom
Website
- Description: Provider of independent advisory and advanced product development services for science and technology initiatives. Through specialist companies Sagentia, Oakland Innovation, OTM Consulting and Leatherhead Food Research, the group collaborates with clients in key vertical markets to deliver clear returns on technology and R&D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Science Group company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pro-Spectus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pro-Spectus
2.2 - Growth funds investing in similar companies to Pro-Spectus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pro-Spectus
4.2 - Public trading comparable groups for Pro-Spectus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →